Current Biomarkers for Endometrial Receptivity
- Authors: Ozlem Erten1, Aysun Tekeli Taskomur2, Mustafa Albayrak3
-
View Affiliations Hide Affiliations1 Department of Obstetrics and Gynecology, School of Medicine, Kutahya Health SciencesUniversity, Kutahya, Turkey 2 Department of Obstetrics and Gynecology, Faculty of Medicine, Amasya University, Amasya,Turkey 3 Department of Obstetrics and Gynecology, Sisli Florence Nightingale Hospital, Istanbul, Turkey
- Source: Biomarkers in Medicine , pp 565-580
- Publication Date: August 2022
- Language: English
Current Biomarkers for Endometrial Receptivity, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815040463/chap22-1.gif
Implantation and the continuation of pregnancy occur through a complicated and sophisticated dialogue, called “cross-talk,” which starts between the embryo and the endometrium in the early stages of oocyte maturation. This dialogue provides synchronization of the journey of the embryo to be implanted with the receptive endometrium. Understanding the activity and function of the hormones and factors involved in this dialogue will provide an understanding of endometrial receptivity, which plays a key role in implantation, and the determination of biomarkers specific for this period. As a result of the development of omics technology, it has become possible to identify biomarkers specific to endometrial receptivity by performing genomic, proteomic, and lipidomic analyses of these hormones and factors. The determination of these biomarkers, their optimization, and making them usable in the clinic will allow increased success in ART.
-
From This Site
/content/books/9789815040463.chap22dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
